IDEAYA Biosciences and Servier report positive results from Phase 2/3 trial of darovasertib/crizotinib combination

FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer

EU approves Sanofi and Regeneron's Dupixent for young children with chronic spontaneous urticaria

Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval

Lupin's Dapagliflozin Tablets launched in US market

Verastem Oncology presents two-year follow-up data on avutometinib and defactinib in recurrent low-grade serous ovarian cancer

DualityBio reports China NMPA acceptance of BLA for T-Pam for treatment of unresectable or metastatic HER2-positive breast cancer

DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules

Eli Lilly launches Foundayo weight‑loss pill in the US

AtaiBeckley reports rapid and durable Phase 2a responses to BPL‑003 in treatment‑resistant depression

Lupin's Dapagliflozin Tablets receive US regulatory approval

Dexcel Pharma's Nintedanib Capsules approved for US launch

FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Immedica Pharma gains European approval to extend Efmody use in adrenal insufficiency

Neurocrine agrees acquisition of Soleno Therapeutics